Disease Info Card

Cerebral Atrophy

Information about Cerebral Atrophy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Cerebral Atrophy

Most recent studies have shown that Cerebral Atrophy shares some biological mechanisms with alzheimers-disease, atrophy, brain-diseases, brain-injuries, cerebrovascular-accident, cognition-disorders, dementia, encephalopathies, epilepsy, hemorrhage, hydrocephalus, hypertensive-disease, impaired-cognition, infarction, multiple-sclerosis, nerve-degeneration, nervousness, neurodegenerative-disorders, sclerosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Cerebral Atrophy, and have been seen in publications frequently: Aging, Brain Development, Brain Segmentation, Cell Death, Coagulation, Cognition, Excretion, Immune Response, Localization, Myelination, Neurogenesis, Neuroprotection, Pathogenesis, Reflex, Secretion, Segmentation, Senescence, Short-term Memory, Translation, Transport

Quite a number of genes have been found to play important roles in Cerebral Atrophy, such as ACAT1, APOE, APP, BDNF, CALB2, CAT, CD55, CRAT, CSF2, HTT, INS, LAMC2, MAPT, POMC, PPP1R3A, PRNP, PSEN1, SLC17A5, SLC25A5. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Cerebral Atrophy Related Genes

click to see detail information for each gene

ACAT1 APOE APP
BDNF CALB2 CAT
CD55 CRAT CSF2
HTT INS LAMC2
MAPT POMC PPP1R3A
PRNP PSEN1 SLC17A5
SLC25A5